Mechanisms by Which Alcohol-Induced Dysbiosis Impairs Host Defense Against Klebsiella Pneumoniae
酒精引起的生态失调损害宿主对肺炎克雷伯氏菌的防御的机制
基本信息
- 批准号:10022082
- 负责人:
- 金额:$ 24.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-20 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdoptive TransferAlcohol consumptionAlcoholsAnimalsBacterial InfectionsBacterial PneumoniaBiological ModelsCD8-Positive T-LymphocytesCell Culture TechniquesCessation of lifeClinical ResearchDataDiseaseEnvironmentEthanolFunctional disorderGerm-FreeGrowth and Development functionHost DefenseImmuneImmune responseImmunologicsImpairmentInfectionIntestinal permeabilityIntestinesInvestigationKlebsiellaKlebsiella InfectionsKlebsiella pneumoniaeLinkLocationLungLung infectionsMediatingMetabolicMorbidity - disease rateMusMycosesPatientsPhasePlayPneumoniaPredispositionPublishingResearchResearch InfrastructureResearch ProposalsRespiratory Tract InfectionsRisk FactorsRoleScientistT cell therapyT-LymphocyteTestingVirulentVirus Diseasesalcohol effectalcohol use disorderdisabilitydysbiosisexperienceexperimental studyglobal healthgut microbiotagut-lung axisimmunoregulationinflammatory disease of the intestinemetabolomicsmicrobialmicrobial communitymicrobiotamortalitymouse modelnovelpathogenpathogenic bacteriapreclinical studyprematureprogramsrespiratorytrafficking
项目摘要
Project Summary/Abstract: Alcohol use disorders (AUD) are a significant global health burden. AUDs are an
established risk factor for bacterial pneumonia, which accounts for ~3.1 million deaths annually. AUD patients
are more frequently infected with highly virulent respiratory pathogens and experience increased morbidity and
mortality from these infections, with Klebsiella pneumoniae being overrepresented in patients with AUDs.
Mortality from Klebsiella pneumonia in patients with AUDs is double that from other pathogens. Further,
preclinical and clinical studies show that alcohol consumption perturbs the normal intestinal microbial
communities (dysbiosis), yet no published data exist linking alcohol-mediated intestinal dysbiosis with respiratory
host defense dysfunction and no attempt has been made to isolate the direct effects of alcohol from those
resulting from intestinal dysbiosis. We have developed a mouse model system that enables us to investigate the
immune modulatory effects of alcohol-associated dysbiosis and isolate the host responses to K. pneumoniae
mediated directly or indirectly by ethanol-associated dysbiosis. Preliminary studies using fecal transfer show that
alcohol-naïve animals recolonized with microbiota isolated from alcohol-fed mice have increased susceptibility
to K. pneumoniae compared to mice recolonized with a control microbiota. The overall hypothesis to be tested
in the proposed study is that alcohol-mediated dysbiosis increases intestinal inflammation and permeability,
which leads to intestinal sequestration of T-cells, altered lung specific T-cell trafficking, and increased
susceptibility to Klebsiella pneumoniae. I will test my hypothesis using both a metabolomics and immunological
approach. Aim 1 will test the prediction that alcohol-dysbiosis promotes intestinal inflammation and permeability.
I will utilize fecal adoptive transfer and cell culture experiments to determine the microbial and metabolic
constituents that promote intestinal inflammation and permeability. Aim 2 will examine the impact of alcohol-dysbiosis
on intestinal T-cell programing and sequestration. I will use T-cell adoptive transfer experiments to
determine the effects of alcohol-dysbiosis on the location/sequestration of T-cells prior to respiratory infection.
Aim 3 will test the prediction that alcohol-dysbiosis impairs lung specific T-cell trafficking. I will assess T-cell
trafficking using microbial and metabolite primed T-cells adoptively transferred into alcohol-naïve animals
recolonized with an alcohol-dysbiotic or pair-fed microbiota.
The proposed studies will use a novel model system to clarify the role of the microbiota in host immune
responses, particularly with regard to AUDs and respiratory infection. The results from these studies will provide
data to support an R01 submission focused on the immunomodulatory effects of alcohol-induced dysbiosis on
the gut-lung axis. The scientific environment, and the research infrastructure provided by the UNMC will be
instrumental in my growth and development as an independent scientist.
项目摘要/摘要:酒精使用障碍(AUD)是一个重大的全球健康负担。AUD是一个
细菌性肺炎的既定风险因素,每年约有310万人死亡。AUD患者
更频繁地感染高毒性呼吸道病原体,发病率增加,
这些感染的死亡率,肺炎克雷伯菌在AUD患者中的比例过高。
在AUD患者中,克雷伯菌肺炎的死亡率是其他病原体的两倍。此外,本发明还
临床前和临床研究表明,酒精消费扰乱了正常的肠道微生物,
社区(生态失调),但没有发表的数据存在联系酒精介导的肠道生态失调与呼吸道
宿主防御功能障碍,并且没有尝试将酒精的直接影响与那些
导致肠道生态失调我们已经开发了一种小鼠模型系统,使我们能够研究
酒精相关的生态失调的免疫调节作用和隔离宿主对K.肺炎
直接或间接由乙醇相关的生态失调介导。使用粪便转移的初步研究表明,
未接触过酒精的动物被从酒精喂养的小鼠中分离出的微生物群感染后,
到K顺序递增的与用对照微生物群接种的小鼠相比,待检验的总体假设
酒精介导的生态失调会增加肠道炎症和通透性,
这导致T细胞的肠隔离,改变肺特异性T细胞运输,并增加
对肺炎克雷伯氏菌的敏感性。我会用代谢组学和免疫学来检验我的假设
approach.目的1将检验酒精微生态失调促进肠道炎症和通透性的预测。
我将利用粪便过继转移和细胞培养实验,以确定微生物和代谢
促进肠道炎症和渗透性的成分。目标2将研究酒精生态失调的影响
肠道T细胞编程和隔离。我会用T细胞过继转移实验
确定酒精生态失调对呼吸道感染前T细胞定位/隔离的影响。
目的3将测试酒精生态失调损害肺特异性T细胞运输的预测。我会评估T细胞
使用微生物和代谢物致敏T细胞过继转移到未接触酒精的动物中的贩运
被酒精或成对喂养的微生物群污染。
拟议的研究将使用一种新的模型系统来阐明微生物群在宿主免疫中的作用。
反应,特别是关于AUDs和呼吸道感染。这些研究的结果将提供
支持R 01提交资料的数据集中于酒精诱导的生态失调对免疫调节的影响,
肠肺轴联合国海洋学委员会提供的科学环境和研究基础设施将
帮助我成长为一名独立的科学家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Derrick R Samuelson其他文献
Derrick R Samuelson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Derrick R Samuelson', 18)}}的其他基金
Gut bacterial metallophores in the development and severity of inflammatory bowel disease
肠道细菌金属载体在炎症性肠病的发生和严重程度中的作用
- 批准号:
10411567 - 财政年份:2022
- 资助金额:
$ 24.79万 - 项目类别:
Gut bacterial metallophores in the development and severity of inflammatory bowel disease
肠道细菌金属载体在炎症性肠病的发生和严重程度中的作用
- 批准号:
10597558 - 财政年份:2022
- 资助金额:
$ 24.79万 - 项目类别:
Mechanisms by Which Alcohol-Induced Dysbiosis Impairs Host Defense Against Klebsiella Pneumoniae
酒精引起的生态失调损害宿主对肺炎克雷伯氏菌的防御的机制
- 批准号:
10247017 - 财政年份:2019
- 资助金额:
$ 24.79万 - 项目类别:
Mechanisms by Which Alcohol-Induced Dysbiosis Impairs Host Defense Against Klebsiella Pneumoniae
酒精引起的生态失调损害宿主对肺炎克雷伯氏菌的防御的机制
- 批准号:
10017457 - 财政年份:2019
- 资助金额:
$ 24.79万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 24.79万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 24.79万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 24.79万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 24.79万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 24.79万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 24.79万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 24.79万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 24.79万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 24.79万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 24.79万 - 项目类别: